Table 2. mRNA content in visceral adipose tissue, liver and skeletal muscle.
3 mo UT-C | 15 mo UT-C | 15 mo UT-R | 15 mo T-C | 15 mo T-R | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
gene | WT | KO | WT | KO | WT | KO | WT | KO | WT | KO | |
V-AT | TNFα | 0.5 ± 0.1 | 0.8 ± 0.2 | 2.3 ± 0.7† | 0.7 ± 0.2# | 0.9 ± 0.2 | 1.3 ± 0.3* | 1.0 ± 0.3 | 0.7 ± 0.2 | 0.9 ± 0.1 | 1.4 ± 0.4 |
IL-6 | 0.8 ± 0.2 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.4 ± 0.1 | 0.9 ± 0.1* | 0.8 ± 0.1* | 1.2 ± 0.1* | 0.7 ± 0.2# | 0.7 ± 0.1 | 0.5 ± 0.1 | |
F4/80 | 0.8 ± 0.2 | 0.5 ± 0.2 | 1.2 ± 0.3 | 0.7 ± 0.3 | 0.6 ± 0.3 | 0.7 ± 0.1 | 1.3 ± 0.2 | 0.7 ± 0.3 | 0.7 ± 0.2 | 0.9 ± 0.3 | |
Liver | TNFα | 0.3 ± 0.03 | 0.3 ± 0.04 | 0.6 ± 0.1† | 0.3 ± 0.03# | 0.5 ± 0.1 | 0.5 ± 0.1* | 0.5 ± 0.1 | 0.4 ± 0.04 | 0.5 ± 0.04 | 0.5 ± 0.1* |
IL-6 | 0.2 ± 0.02 | 0.2 ± 0.01 | 0.2 ± 0.01 | 0.2 ± 0.02 | 0.1 ± 0.01 | 0.2 ± 0.03 | 0.2 ± 0.02 | 0.2 ± 0.02 | 0.2 ± 0.02 | 0.2 ± 0.03 | |
F4/80 | 0.6 ± 0.04 | 0.5 ± 0.1 | 0.7 ± 0.1 | 0.4 ± 0.1# | 0.5 ± 0.1 | 0.7 ± 0.1 | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.5 ± 0.03 | 0.7 ± 0.1 | |
SkM | TNFα | 1.1 ± 0.1 | 0.7 ± 0.1 | 1.4 ± 0.2 | 1.6 ± 0.3† | 1.2 ± 0.3 | 1.6 ± 0.2 | 2.6 ± 0.6* | 1.9 ± 0.2 | 1.9 ± 0.3 | 2.4 ± 0.4 |
IL-6 | 0.7 ± 0.1 | 0.5 ± 0.1 | 1.0 ± 0.1(†) | 1.0 ± 0.1† | 0.7 ± 0.2 | 1.0 ± 0.1 | 0.7 ± 0.1* | 0.7 ± 0.1* | 0.9 ± 0.1* | 0.7 ± 0.1* | |
F4/80 | 2.4 ± 0.3 | 2.3 ± 0.3 | 1.2 ± 0.2† | 1.6 ± 0.3 | 0.8 ± 0.2 | 1.6 ± 0.3# | 3.7 ± 1.1* | 3.0 ± 0.4* | 2.0 ± 0.3* | 3.5 ± 0.4#* |
Significantly different from 3 month old UT-C within genotype, p<0.05.
Tends to be significantly different from 3 month old UT-C within genotype, 0.05≤p<0.1.
Significantly different from 15 month old UT-C within genotype, p<0.05.
Significantly different from WT within group, p<0.05.